Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 12356689)

Published in Fam Pract on October 01, 2002

Authors

H Mönig1, D Marquardt, T Arendt, S Kloehn

Author Affiliations

1: Department of General Internal Medicine, I Med. Klinik der KAU Kiel, University of Kiel, Schittenhelmstrasse 12, D-24105 Kiel, Germany. hmoenig@1med.uni-kiel.de

Articles by these authors

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (1983) 1.91

Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience (1985) 1.59

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50

Teaching family-centered perinatal care in family medicine, Part 2. Fam Med (1992) 1.37

Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging (2001) 1.27

Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience (1999) 1.11

Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol (2000) 1.08

Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res (2001) 1.05

Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. Brain Res Mol Brain Res (1999) 1.04

Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem (2004) 1.03

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? J Chem Neuroanat (2000) 1.00

Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm (Vienna) (1999) 0.98

Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem (1991) 0.97

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res (2001) 0.97

Aggrecan: Beyond cartilage and into the brain. Int J Biochem Cell Biol (2012) 0.95

The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl (1998) 0.95

Postmortem changes in the phosphorylation state of tau-protein in the rat brain. Neurobiol Aging (1999) 0.95

Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (1998) 0.94

Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit. Neuroscience (2007) 0.94

Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut (1999) 0.93

Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience (2010) 0.93

Connective tissue growth factor in Alzheimer's disease. Neuroscience (2003) 0.93

Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes (2004) 0.93

Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet (1984) 0.93

Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res (2000) 0.92

Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J Biol Chem (1990) 0.90

Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia. Neuroscience (2001) 0.89

Morphometry of the corpus callosum in patients with questionable and mild dementia. J Neurol Neurosurg Psychiatry (2002) 0.89

Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience (1994) 0.89

Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter. J Physiol Paris (1999) 0.88

Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease--a quantitative Golgi investigation. Neuroscience (1986) 0.87

Unique features of extracellular matrix in the mouse medial nucleus of trapezoid body--implications for physiological functions. Neuroscience (2012) 0.87

Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport (2001) 0.86

Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience (1999) 0.86

Cardiac tamponade--a rare complication in acute pancreatitis. Z Gastroenterol (1997) 0.85

The core-shell dichotomy of nucleus accumbens in the rhesus monkey as revealed by double-immunofluorescence and morphology of cholinergic interneurons. Brain Res (2000) 0.85

Correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia. J Clin Neurophysiol (2001) 0.85

Use of designed peptide linkers and recombinant hemoglobin mutants for drug delivery: in vitro release of an angiotensin II analog and kinetic modeling of delivery. Bioconjug Chem (1997) 0.84

Santorini's duct--risk factor for acute pancreatitis or protective morphologic variant? Experiments in rabbits. Eur J Gastroenterol Hepatol (1997) 0.84

Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes (2004) 0.84

Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment. Eur Psychiatry (2009) 0.84

Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM. Biochem Pharmacol (1989) 0.83

The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis). Eur J Clin Invest (2000) 0.83

The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats. Behav Brain Res (1991) 0.83

A case of Behçet's syndrome presenting with Dieulafoy's ulcer. Z Gastroenterol (1997) 0.83

Perisynaptic aggrecan-based extracellular matrix coats in the human lateral geniculate body devoid of perineuronal nets. J Neurosci Res (2011) 0.82

Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases--implications for the euthyroid sick syndrome. Intensive Care Med (1999) 0.82

Perineuronal and perisynaptic extracellular matrix in the human spinal cord. Neuroscience (2013) 0.81

Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology. Neurobiol Aging (1999) 0.81

Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons. J Neural Transm (Vienna) (2000) 0.81

Induction of p21ras in Alzheimer pathology. Neuroreport (1995) 0.81

Enhanced Ras activity preserves dendritic size and extension as well as synaptic contacts of neurons after functional deprivation in synRas mice. Eur J Neurosci (2008) 0.80

Infected bile-induced acute pancreatitis in rabbits. The role of bacteria. Int J Pancreatol (1998) 0.80

Alzheimer plaques and cortical cholinergic innervation. Neuroscience (1986) 0.80

Anti-AGEing defences against Alzheimer's disease. Biochem Soc Trans (2003) 0.80

Alzheimer's disease in senile dementia: loss of neurones in the basal forebrain. Whitehouse, P., Price, D., Struble, R., Clarke, A., Coyle, J. and Delong, M. Science (1982), 215, 1237-1239. Int J Geriatr Psychiatry (1997) 0.80

Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. I. Mitogen-activated protein kinase cascade. Neuroscience (2001) 0.79

Differential changes in the expression of AMPA receptors genes in rat brain after chronic exposure to ethanol: an in situ hybridization study. J Hirnforsch (1997) 0.79

Functional changes in field L complex during song development of juvenile male zebra finches. Brain Res Dev Brain Res (2000) 0.79

Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison. Neurobiol Aging (2001) 0.79

Biliary pancreatic reflux-induced acute pancreatitis--myth or possibility? Eur J Gastroenterol Hepatol (1999) 0.79

Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease. Acta Neuropathol (1984) 0.79

Guinea-pig primary cell cultures provide a model to study expression and amyloidogenic processing of endogenous amyloid precursor protein. Neuroscience (2000) 0.79

Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol (2000) 0.79

Distribution of isoforms of the microtubule-associated protein tau in grey and white matter areas of human brain: a two-dimensional gelelectrophoretic analysis. FEBS Lett (1996) 0.79

Aggrecan-based extracellular matrix shows unique cortical features and conserved subcortical principles of mammalian brain organization in the Madagascan lesser hedgehog tenrec (Echinops telfairi Martin, 1838). Neuroscience (2009) 0.79

Association between global brain volume and the rate of cognitive change in elderly humans without dementia. Dement Geriatr Cogn Disord (2005) 0.78

Chondroitin sulphate proteoglycan-based perineuronal net establishment is largely activity-independent in chick visual system. J Chem Neuroanat (2010) 0.78

Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease. Neurosci Lett (1984) 0.78

Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology. Neuroscience (2001) 0.78

Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat. J Hirnforsch (1998) 0.77

Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease. J Neural Transm Suppl (2003) 0.77

Phosphorylation of the tau protein sequence 199-205 in the hippocampal CA3 region of Syrian hamsters in adulthood and during aging. Brain Res (2005) 0.77

Nitric oxide and Alzheimer's disease. J Hirnforsch (1998) 0.77

Expression and distribution of prolactin receptor in normal, fibrotic, and cirrhotic human liver. Exp Clin Endocrinol Diabetes (2006) 0.77

Alterations in content and phosphorylation state of cytoskeletal proteins in the sciatic nerve during ageing and in Alzheimer's disease. J Neural Transm (Vienna) (1999) 0.77

Effect of leukotriene inhibitors on evolution of experimental brain contusions. Neuropathol Appl Neurobiol (2012) 0.77

Co-expression of APP with cNOS but not iNOS after cortical injury in rat. Neuroreport (1997) 0.77

Two distinct populations of cholinergic neurons in the septum of raccoon (Procyon lotor): evidence for a separate subset in the lateral septum. J Comp Neurol (1999) 0.77

Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis. Horm Metab Res (2001) 0.77

Cellular and ultra structural evidence for cytoskeletal localization of prolyl endopeptidase-like protein in neurons. Neuroscience (2013) 0.77

Changes of activity and isozyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease. J Neurochem (1996) 0.77

Hypoxic renal tissue damage by endothelin-mediated arterial vasoconstriction during radioangiography in man. Adv Exp Med Biol (1998) 0.77

Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products. J Neural Transm (Vienna) (2007) 0.77

Electron microscopic evidence for different myelination of rat septohippocampal fibres. Neuroreport (2001) 0.76

The cholinergic system in aging. Gerontology (1987) 0.76

[Cushing syndrome with life-threatening infectious complications]. Dtsch Med Wochenschr (1997) 0.76

Increase in vulnerability of middle-aged rat brain to lead by cerebral energy depletion. Brain Res Bull (2000) 0.76

Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology (1991) 0.76

Blunted nocturnal TSH surge does not indicate central hypothyroidism in patients after pituitary surgery. Exp Clin Endocrinol Diabetes (1999) 0.76

Recommendations for immunizations in HIV-infected individuals. West J Med (1997) 0.75

Immunofluorescence and immunoelectron microscopic evidence for differences in myelination of GABAergic and cholinergic septohippocampal fibres. Int J Dev Neurosci (2001) 0.75

NGF level in the rat sciatic nerve is decreased after long-term consumption of ethanol. Neuroreport (1996) 0.75

Chronic alcohol intoxication in rats leads to a strong but transient increase in NGF levels in distinct brain regions. J Neural Transm (Vienna) (2005) 0.75

Occult esophageal dysplasia disclosed by Lugol chromoendoscopy? Endoscopy (2000) 0.75

Different myelination of rat septohippocampal fibres as revealed by immunofluorescence double-labelling. Brain Res (2000) 0.75

Antihistamines and the heart. West J Med (1993) 0.75

[Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr (1998) 0.75